In 25% of DNA samples from sarcomas with qPCR values indicating Cdkn2a loss, exon 2 copy numbers were <0.2, which suggested the presence of a homozygous deletion in ∼80% of tumor cells, compatible with an early event in tumorigenesis. The gene discussed is CDKN2A; the disease is sarcoma.